PharmiWeb2 小时
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...
来自MSN14 天
Nuclein’s DASH SARS-CoV-2 & Flu A/B Test gains FDA clearance and CLIA waiver
Nuclein’s DASH SARS-CoV-2 & Flu A/B Test, which is designed for use with the DASH Rapid PCR System, has gained the US Food and Drug Administration (FDA) 510(k) clearance, as well as a Clinical ...
manilatimes13 天
Trinity Investors Celebrates Nuclein's Dual FDA Clearance and CLIA Waiver for DASH® SARS ...
SOUTHLAKE, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Trinity Investors, a leading alternative asset management firm, proudly ...
Business Insider13 天
Trinity Investors Celebrates Nuclein’s Dual FDA Clearance and CLIA Waiver for DASH® SARS ...
Nuclein has secured U.S. Food and Drug Administration (FDA) 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for its DASH® SARS-CoV-2 & Flu A/B Test, designed for ...
The Victoria Advocate16 天
Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B ...
"Nuclein was founded with a vision to enable simple, affordable, rapid, and accurate testing for everyone," said Alan Blake, CEO and co-founder of Nuclein. "FDA 510(k) clearance and a CLIA waiver ...
Stockhead on MSN8 天
Lumos teams with MedPro to expand US reach of FebriDx point-of-care respiratory test
Lumos Diagnostics (ASX:LDX) said MedPro would offer contract sales coverage across the health system, government and ...